New study hopes to predict hodgkin lymphoma outcomes better
NCT ID NCT06822855
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study is looking for better ways to predict how Hodgkin lymphoma will progress. Researchers will analyze genetic material from tumor samples and blood tests, along with PET scan images, from 755 patients. The goal is to identify markers that could help doctors personalize treatment, potentially increasing cure rates while reducing long-term side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to more personalized treatment plans for Hodgkin lymphoma, potentially improving cure rates and reducing side effects.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new therapy. The findings may not immediately change clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLASSICAL HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O.S.G. Moscati
RECRUITINGAvellino, Italy
-
AOU Città della Salute e della Scienza
RECRUITINGTorino, Italy
-
AOU Città della salute e della Scienza, "Le Molinette"
RECRUITINGTorino, Italy
-
ASST Grande Ospedale Metropolitano Niguarda
RECRUITINGMilan, MI, 20162, Italy
-
AUSL Piacenza
RECRUITINGPiacenza, Italy
-
Azienda Ospedaliera "Ospedali Riuniti Villa Sofia-Cervello"
RECRUITINGPalermo, Italy
-
Azienda Ospedaliera Santa Maria - Terni
RECRUITINGTerni, 05100, Italy
-
Azienda Ospedaliera di Perugia
RECRUITINGPerugia, Italy
-
Azienda USL IRCCS di Reggio Emilia
RECRUITINGReggio Emilia, RE, 42123, Italy
-
Istituto Oncologico Veneto
RECRUITINGPadova, Italy
-
Ospedale S. Maria della Misericordia, Azienda Ospedaliera di Perugia
RECRUITINGPerugia, Italy
-
Spedali Civili Brescia
RECRUITINGBrescia, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new nucleotide analogue boost cancer treatment?
- Can a drug duo outsmart resistant lymphomas?
- Immunotherapy may let some hodgkin lymphoma patients avoid intensive chemo and radiation
- Two-Drug combo aims to tackle Hard-to-Treat hodgkin lymphoma
- New drug combo aims to tackle Hard-to-Treat hodgkin lymphoma
- Engineered donor cells take on lymphoma in early trial